Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill
A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than ...
Gilead’s biannual HIV shot reduced risk of infections by 96 percent, company says
Drugmaker Gilead Science announced Thursday that its biannual injections to prevent against HIV had slashed the risk of ...
WAMC3d
Ukraine keeps up the fight against HIV while fighting a war
Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...
Twice-yearly injection reduced HIV infections by 96 percent, company says
Lenacapavir, a new HIV prevention drug, has proven to dramatically reduce the risk of infection according to data reported ...
radiojamaicanewsonline3d
Alarm raised amid rise in HIV infections among Caribbean youth
The Joint United Nations Programme on HIV/AIDS has raised alarm over the increasing incidence of HIV among young people in ...
Gilead’s HIV-prevention drug cut infections by 96%, boosting stock
Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, ...
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
Gilead Sciences' Phase 3 trial results show twice-yearly HIV-1 capsid inhibitor lenacapavir reduced HIV infections by 96%, ...
Science Daily7d
Targeted immune intervention and stopping ART in model of SIV infection leads to control of viral replication and reservoirs
Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...
Gilead’s HIV Shot Reduced Infections By 96% In Late-Stage Trial—Beating Daily Pill
Gilead Science’s twice-yearly shot for treating HIV prevented new infections by 96% among patients in a late-stage trial, ...
Fred Hutch13d
Zeroing in on vaginal microbes that most increase HIV risk
The largest-ever study of women in sub-Saharan Africa zeroes in on the combination of bacterial vaginosis-associated bacteria ...
Gilead's twice-yearly shot cut HIV infections by 96% in trial
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said Thursday. The data sets ...
CNN10d
Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill
A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.